1. Home
  2. GRDN vs PGNY Comparison

GRDN vs PGNY Comparison

Compare GRDN & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRDN
  • PGNY
  • Stock Information
  • Founded
  • GRDN 2004
  • PGNY 2008
  • Country
  • GRDN United States
  • PGNY United States
  • Employees
  • GRDN N/A
  • PGNY N/A
  • Industry
  • GRDN Retail-Drug Stores and Proprietary Stores
  • PGNY Misc Health and Biotechnology Services
  • Sector
  • GRDN Consumer Staples
  • PGNY Health Care
  • Exchange
  • GRDN Nasdaq
  • PGNY Nasdaq
  • Market Cap
  • GRDN 1.7B
  • PGNY 1.8B
  • IPO Year
  • GRDN 2024
  • PGNY 2019
  • Fundamental
  • Price
  • GRDN $31.52
  • PGNY $24.52
  • Analyst Decision
  • GRDN Strong Buy
  • PGNY Buy
  • Analyst Count
  • GRDN 2
  • PGNY 8
  • Target Price
  • GRDN $30.00
  • PGNY $26.88
  • AVG Volume (30 Days)
  • GRDN 345.1K
  • PGNY 2.0M
  • Earning Date
  • GRDN 11-10-2025
  • PGNY 11-06-2025
  • Dividend Yield
  • GRDN N/A
  • PGNY N/A
  • EPS Growth
  • GRDN N/A
  • PGNY 2.96
  • EPS
  • GRDN 0.64
  • PGNY 0.62
  • Revenue
  • GRDN $1,389,638,000.00
  • PGNY $1,268,689,000.00
  • Revenue This Year
  • GRDN $16.33
  • PGNY $10.00
  • Revenue Next Year
  • GRDN $2.10
  • PGNY $9.42
  • P/E Ratio
  • GRDN $49.27
  • PGNY $39.59
  • Revenue Growth
  • GRDN 18.68
  • PGNY 11.41
  • 52 Week Low
  • GRDN $17.78
  • PGNY $13.39
  • 52 Week High
  • GRDN $37.43
  • PGNY $26.76
  • Technical
  • Relative Strength Index (RSI)
  • GRDN 75.47
  • PGNY 71.51
  • Support Level
  • GRDN $27.39
  • PGNY $18.16
  • Resistance Level
  • GRDN $37.43
  • PGNY $23.98
  • Average True Range (ATR)
  • GRDN 1.63
  • PGNY 0.80
  • MACD
  • GRDN 0.27
  • PGNY 0.69
  • Stochastic Oscillator
  • GRDN 42.21
  • PGNY 88.04

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

About PGNY Progyny Inc.

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Share on Social Networks: